Oncology PharmaONPH
13F holders, Q3 2024 (September 30)1holders
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Oncology Pharma Inc. (ONPH) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holder was Studio Investment Management LLC ($0).
- Company
- Oncology Pharma Inc.
- CUSIP
- 68235J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 20 shares bought and 974 shares sold, net −954 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Studio Investment Management LLC | 0.00% | New | 20 | $0 |
"% of holder's portfolio" is ONPH's weight in each manager's 13F, not the share of Oncology Pharma Inc. the manager owns.